Global Androgen Receptor (AR) Antagonist Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Androgen receptor (AR) antagonists are a class of drugs that bind to androgen receptors, thereby preventing or reducing the biological effects of androgens.
The global Androgen Receptor (AR) Antagonist market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Androgen Receptor (AR) Antagonist Industry Forecast” looks at past sales and reviews total world Androgen Receptor (AR) Antagonist sales in 2023, providing a comprehensive analysis by region and market sector of projected Androgen Receptor (AR) Antagonist sales for 2024 through 2030. With Androgen Receptor (AR) Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androgen Receptor (AR) Antagonist industry.
This Insight Report provides a comprehensive analysis of the global Androgen Receptor (AR) Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androgen Receptor (AR) Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androgen Receptor (AR) Antagonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androgen Receptor (AR) Antagonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androgen Receptor (AR) Antagonist.
United States market for Androgen Receptor (AR) Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Androgen Receptor (AR) Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Androgen Receptor (AR) Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Androgen Receptor (AR) Antagonist players cover R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Receptor (AR) Antagonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Androgen Receptor (AR) Antagonist market?
What factors are driving Androgen Receptor (AR) Antagonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Androgen Receptor (AR) Antagonist market opportunities vary by end market size?
How does Androgen Receptor (AR) Antagonist break out by Type, by Application?
Androgen receptor (AR) antagonists are a class of drugs that bind to androgen receptors, thereby preventing or reducing the biological effects of androgens.
The global Androgen Receptor (AR) Antagonist market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Androgen Receptor (AR) Antagonist Industry Forecast” looks at past sales and reviews total world Androgen Receptor (AR) Antagonist sales in 2023, providing a comprehensive analysis by region and market sector of projected Androgen Receptor (AR) Antagonist sales for 2024 through 2030. With Androgen Receptor (AR) Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Androgen Receptor (AR) Antagonist industry.
This Insight Report provides a comprehensive analysis of the global Androgen Receptor (AR) Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Androgen Receptor (AR) Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Androgen Receptor (AR) Antagonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Androgen Receptor (AR) Antagonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Androgen Receptor (AR) Antagonist.
United States market for Androgen Receptor (AR) Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Androgen Receptor (AR) Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Androgen Receptor (AR) Antagonist is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Androgen Receptor (AR) Antagonist players cover R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Androgen Receptor (AR) Antagonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Steroidal AR Antagonists
- Nonsteroidal AR Antagonists
- Prostate Cancer
- Breast Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- R&D Systems
- Bayer
- Janssen Pharmaceuticals
- Pfizer
- Astellas Pharma
- Kaituo Pharmaceutical
- Hengrui Medicine
What is the 10-year outlook for the global Androgen Receptor (AR) Antagonist market?
What factors are driving Androgen Receptor (AR) Antagonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Androgen Receptor (AR) Antagonist market opportunities vary by end market size?
How does Androgen Receptor (AR) Antagonist break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Androgen Receptor (AR) Antagonist Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Androgen Receptor (AR) Antagonist by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Androgen Receptor (AR) Antagonist by Country/Region, 2019, 2023 & 2030
2.2 Androgen Receptor (AR) Antagonist Segment by Type
2.2.1 Steroidal AR Antagonists
2.2.2 Nonsteroidal AR Antagonists
2.3 Androgen Receptor (AR) Antagonist Sales by Type
2.3.1 Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
2.3.2 Global Androgen Receptor (AR) Antagonist Revenue and Market Share by Type (2019-2024)
2.3.3 Global Androgen Receptor (AR) Antagonist Sale Price by Type (2019-2024)
2.4 Androgen Receptor (AR) Antagonist Segment by Application
2.4.1 Prostate Cancer
2.4.2 Breast Cancer
2.4.3 Others
2.5 Androgen Receptor (AR) Antagonist Sales by Application
2.5.1 Global Androgen Receptor (AR) Antagonist Sale Market Share by Application (2019-2024)
2.5.2 Global Androgen Receptor (AR) Antagonist Revenue and Market Share by Application (2019-2024)
2.5.3 Global Androgen Receptor (AR) Antagonist Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Androgen Receptor (AR) Antagonist Breakdown Data by Company
3.1.1 Global Androgen Receptor (AR) Antagonist Annual Sales by Company (2019-2024)
3.1.2 Global Androgen Receptor (AR) Antagonist Sales Market Share by Company (2019-2024)
3.2 Global Androgen Receptor (AR) Antagonist Annual Revenue by Company (2019-2024)
3.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Company (2019-2024)
3.2.2 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company (2019-2024)
3.3 Global Androgen Receptor (AR) Antagonist Sale Price by Company
3.4 Key Manufacturers Androgen Receptor (AR) Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Androgen Receptor (AR) Antagonist Product Location Distribution
3.4.2 Players Androgen Receptor (AR) Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANDROGEN RECEPTOR (AR) ANTAGONIST BY GEOGRAPHIC REGION
4.1 World Historic Androgen Receptor (AR) Antagonist Market Size by Geographic Region (2019-2024)
4.1.1 Global Androgen Receptor (AR) Antagonist Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Androgen Receptor (AR) Antagonist Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Androgen Receptor (AR) Antagonist Market Size by Country/Region (2019-2024)
4.2.1 Global Androgen Receptor (AR) Antagonist Annual Sales by Country/Region (2019-2024)
4.2.2 Global Androgen Receptor (AR) Antagonist Annual Revenue by Country/Region (2019-2024)
4.3 Americas Androgen Receptor (AR) Antagonist Sales Growth
4.4 APAC Androgen Receptor (AR) Antagonist Sales Growth
4.5 Europe Androgen Receptor (AR) Antagonist Sales Growth
4.6 Middle East & Africa Androgen Receptor (AR) Antagonist Sales Growth
5 AMERICAS
5.1 Americas Androgen Receptor (AR) Antagonist Sales by Country
5.1.1 Americas Androgen Receptor (AR) Antagonist Sales by Country (2019-2024)
5.1.2 Americas Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024)
5.2 Americas Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
5.3 Americas Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Receptor (AR) Antagonist Sales by Region
6.1.1 APAC Androgen Receptor (AR) Antagonist Sales by Region (2019-2024)
6.1.2 APAC Androgen Receptor (AR) Antagonist Revenue by Region (2019-2024)
6.2 APAC Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
6.3 APAC Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Androgen Receptor (AR) Antagonist by Country
7.1.1 Europe Androgen Receptor (AR) Antagonist Sales by Country (2019-2024)
7.1.2 Europe Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024)
7.2 Europe Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
7.3 Europe Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Androgen Receptor (AR) Antagonist by Country
8.1.1 Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Country (2019-2024)
8.1.2 Middle East & Africa Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024)
8.2 Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
8.3 Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Androgen Receptor (AR) Antagonist
10.3 Manufacturing Process Analysis of Androgen Receptor (AR) Antagonist
10.4 Industry Chain Structure of Androgen Receptor (AR) Antagonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Androgen Receptor (AR) Antagonist Distributors
11.3 Androgen Receptor (AR) Antagonist Customer
12 WORLD FORECAST REVIEW FOR ANDROGEN RECEPTOR (AR) ANTAGONIST BY GEOGRAPHIC REGION
12.1 Global Androgen Receptor (AR) Antagonist Market Size Forecast by Region
12.1.1 Global Androgen Receptor (AR) Antagonist Forecast by Region (2025-2030)
12.1.2 Global Androgen Receptor (AR) Antagonist Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Androgen Receptor (AR) Antagonist Forecast by Type (2025-2030)
12.7 Global Androgen Receptor (AR) Antagonist Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 R&D Systems
13.1.1 R&D Systems Company Information
13.1.2 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.1.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 R&D Systems Main Business Overview
13.1.5 R&D Systems Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.2.3 Bayer Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Janssen Pharmaceuticals
13.3.1 Janssen Pharmaceuticals Company Information
13.3.2 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.3.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Janssen Pharmaceuticals Main Business Overview
13.3.5 Janssen Pharmaceuticals Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.4.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Astellas Pharma
13.5.1 Astellas Pharma Company Information
13.5.2 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.5.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Astellas Pharma Main Business Overview
13.5.5 Astellas Pharma Latest Developments
13.6 Kaituo Pharmaceutical
13.6.1 Kaituo Pharmaceutical Company Information
13.6.2 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.6.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kaituo Pharmaceutical Main Business Overview
13.6.5 Kaituo Pharmaceutical Latest Developments
13.7 Hengrui Medicine
13.7.1 Hengrui Medicine Company Information
13.7.2 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.7.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hengrui Medicine Main Business Overview
13.7.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Androgen Receptor (AR) Antagonist Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Androgen Receptor (AR) Antagonist by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Androgen Receptor (AR) Antagonist by Country/Region, 2019, 2023 & 2030
2.2 Androgen Receptor (AR) Antagonist Segment by Type
2.2.1 Steroidal AR Antagonists
2.2.2 Nonsteroidal AR Antagonists
2.3 Androgen Receptor (AR) Antagonist Sales by Type
2.3.1 Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
2.3.2 Global Androgen Receptor (AR) Antagonist Revenue and Market Share by Type (2019-2024)
2.3.3 Global Androgen Receptor (AR) Antagonist Sale Price by Type (2019-2024)
2.4 Androgen Receptor (AR) Antagonist Segment by Application
2.4.1 Prostate Cancer
2.4.2 Breast Cancer
2.4.3 Others
2.5 Androgen Receptor (AR) Antagonist Sales by Application
2.5.1 Global Androgen Receptor (AR) Antagonist Sale Market Share by Application (2019-2024)
2.5.2 Global Androgen Receptor (AR) Antagonist Revenue and Market Share by Application (2019-2024)
2.5.3 Global Androgen Receptor (AR) Antagonist Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Androgen Receptor (AR) Antagonist Breakdown Data by Company
3.1.1 Global Androgen Receptor (AR) Antagonist Annual Sales by Company (2019-2024)
3.1.2 Global Androgen Receptor (AR) Antagonist Sales Market Share by Company (2019-2024)
3.2 Global Androgen Receptor (AR) Antagonist Annual Revenue by Company (2019-2024)
3.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Company (2019-2024)
3.2.2 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company (2019-2024)
3.3 Global Androgen Receptor (AR) Antagonist Sale Price by Company
3.4 Key Manufacturers Androgen Receptor (AR) Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Androgen Receptor (AR) Antagonist Product Location Distribution
3.4.2 Players Androgen Receptor (AR) Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANDROGEN RECEPTOR (AR) ANTAGONIST BY GEOGRAPHIC REGION
4.1 World Historic Androgen Receptor (AR) Antagonist Market Size by Geographic Region (2019-2024)
4.1.1 Global Androgen Receptor (AR) Antagonist Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Androgen Receptor (AR) Antagonist Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Androgen Receptor (AR) Antagonist Market Size by Country/Region (2019-2024)
4.2.1 Global Androgen Receptor (AR) Antagonist Annual Sales by Country/Region (2019-2024)
4.2.2 Global Androgen Receptor (AR) Antagonist Annual Revenue by Country/Region (2019-2024)
4.3 Americas Androgen Receptor (AR) Antagonist Sales Growth
4.4 APAC Androgen Receptor (AR) Antagonist Sales Growth
4.5 Europe Androgen Receptor (AR) Antagonist Sales Growth
4.6 Middle East & Africa Androgen Receptor (AR) Antagonist Sales Growth
5 AMERICAS
5.1 Americas Androgen Receptor (AR) Antagonist Sales by Country
5.1.1 Americas Androgen Receptor (AR) Antagonist Sales by Country (2019-2024)
5.1.2 Americas Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024)
5.2 Americas Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
5.3 Americas Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Androgen Receptor (AR) Antagonist Sales by Region
6.1.1 APAC Androgen Receptor (AR) Antagonist Sales by Region (2019-2024)
6.1.2 APAC Androgen Receptor (AR) Antagonist Revenue by Region (2019-2024)
6.2 APAC Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
6.3 APAC Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Androgen Receptor (AR) Antagonist by Country
7.1.1 Europe Androgen Receptor (AR) Antagonist Sales by Country (2019-2024)
7.1.2 Europe Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024)
7.2 Europe Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
7.3 Europe Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Androgen Receptor (AR) Antagonist by Country
8.1.1 Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Country (2019-2024)
8.1.2 Middle East & Africa Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024)
8.2 Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Type (2019-2024)
8.3 Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Androgen Receptor (AR) Antagonist
10.3 Manufacturing Process Analysis of Androgen Receptor (AR) Antagonist
10.4 Industry Chain Structure of Androgen Receptor (AR) Antagonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Androgen Receptor (AR) Antagonist Distributors
11.3 Androgen Receptor (AR) Antagonist Customer
12 WORLD FORECAST REVIEW FOR ANDROGEN RECEPTOR (AR) ANTAGONIST BY GEOGRAPHIC REGION
12.1 Global Androgen Receptor (AR) Antagonist Market Size Forecast by Region
12.1.1 Global Androgen Receptor (AR) Antagonist Forecast by Region (2025-2030)
12.1.2 Global Androgen Receptor (AR) Antagonist Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Androgen Receptor (AR) Antagonist Forecast by Type (2025-2030)
12.7 Global Androgen Receptor (AR) Antagonist Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 R&D Systems
13.1.1 R&D Systems Company Information
13.1.2 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.1.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 R&D Systems Main Business Overview
13.1.5 R&D Systems Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.2.3 Bayer Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Janssen Pharmaceuticals
13.3.1 Janssen Pharmaceuticals Company Information
13.3.2 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.3.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Janssen Pharmaceuticals Main Business Overview
13.3.5 Janssen Pharmaceuticals Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.4.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Astellas Pharma
13.5.1 Astellas Pharma Company Information
13.5.2 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.5.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Astellas Pharma Main Business Overview
13.5.5 Astellas Pharma Latest Developments
13.6 Kaituo Pharmaceutical
13.6.1 Kaituo Pharmaceutical Company Information
13.6.2 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.6.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kaituo Pharmaceutical Main Business Overview
13.6.5 Kaituo Pharmaceutical Latest Developments
13.7 Hengrui Medicine
13.7.1 Hengrui Medicine Company Information
13.7.2 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
13.7.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hengrui Medicine Main Business Overview
13.7.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Androgen Receptor (AR) Antagonist Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Androgen Receptor (AR) Antagonist Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Steroidal AR Antagonists
Table 4. Major Players of Nonsteroidal AR Antagonists
Table 5. Global Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 6. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Table 7. Global Androgen Receptor (AR) Antagonist Revenue by Type (2019-2024) & ($ million)
Table 8. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2019-2024)
Table 9. Global Androgen Receptor (AR) Antagonist Sale Price by Type (2019-2024) & (US$/Ton)
Table 10. Global Androgen Receptor (AR) Antagonist Sale by Application (2019-2024) & (Kilotons)
Table 11. Global Androgen Receptor (AR) Antagonist Sale Market Share by Application (2019-2024)
Table 12. Global Androgen Receptor (AR) Antagonist Revenue by Application (2019-2024) & ($ million)
Table 13. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2019-2024)
Table 14. Global Androgen Receptor (AR) Antagonist Sale Price by Application (2019-2024) & (US$/Ton)
Table 15. Global Androgen Receptor (AR) Antagonist Sales by Company (2019-2024) & (Kilotons)
Table 16. Global Androgen Receptor (AR) Antagonist Sales Market Share by Company (2019-2024)
Table 17. Global Androgen Receptor (AR) Antagonist Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company (2019-2024)
Table 19. Global Androgen Receptor (AR) Antagonist Sale Price by Company (2019-2024) & (US$/Ton)
Table 20. Key Manufacturers Androgen Receptor (AR) Antagonist Producing Area Distribution and Sales Area
Table 21. Players Androgen Receptor (AR) Antagonist Products Offered
Table 22. Androgen Receptor (AR) Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Androgen Receptor (AR) Antagonist Sales by Geographic Region (2019-2024) & (Kilotons)
Table 26. Global Androgen Receptor (AR) Antagonist Sales Market Share Geographic Region (2019-2024)
Table 27. Global Androgen Receptor (AR) Antagonist Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Androgen Receptor (AR) Antagonist Sales by Country/Region (2019-2024) & (Kilotons)
Table 30. Global Androgen Receptor (AR) Antagonist Sales Market Share by Country/Region (2019-2024)
Table 31. Global Androgen Receptor (AR) Antagonist Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
Table 34. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2024)
Table 35. Americas Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 37. Americas Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 38. APAC Androgen Receptor (AR) Antagonist Sales by Region (2019-2024) & (Kilotons)
Table 39. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Region (2019-2024)
Table 40. APAC Androgen Receptor (AR) Antagonist Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 42. APAC Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 43. Europe Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
Table 44. Europe Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 46. Europe Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 47. Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
Table 48. Middle East & Africa Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 50. Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 51. Key Market Drivers & Growth Opportunities of Androgen Receptor (AR) Antagonist
Table 52. Key Market Challenges & Risks of Androgen Receptor (AR) Antagonist
Table 53. Key Industry Trends of Androgen Receptor (AR) Antagonist
Table 54. Androgen Receptor (AR) Antagonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Androgen Receptor (AR) Antagonist Distributors List
Table 57. Androgen Receptor (AR) Antagonist Customer List
Table 58. Global Androgen Receptor (AR) Antagonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 59. Global Androgen Receptor (AR) Antagonist Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Androgen Receptor (AR) Antagonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 61. Americas Androgen Receptor (AR) Antagonist Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Androgen Receptor (AR) Antagonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 63. APAC Androgen Receptor (AR) Antagonist Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Androgen Receptor (AR) Antagonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 65. Europe Androgen Receptor (AR) Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 67. Middle East & Africa Androgen Receptor (AR) Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Androgen Receptor (AR) Antagonist Sales Forecast by Type (2025-2030) & (Kilotons)
Table 69. Global Androgen Receptor (AR) Antagonist Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Androgen Receptor (AR) Antagonist Sales Forecast by Application (2025-2030) & (Kilotons)
Table 71. Global Androgen Receptor (AR) Antagonist Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. R&D Systems Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 73. R&D Systems Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 74. R&D Systems Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. R&D Systems Main Business
Table 76. R&D Systems Latest Developments
Table 77. Bayer Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 79. Bayer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. Janssen Pharmaceuticals Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 83. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 84. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Janssen Pharmaceuticals Main Business
Table 86. Janssen Pharmaceuticals Latest Developments
Table 87. Pfizer Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 89. Pfizer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Astellas Pharma Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 93. Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 94. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Astellas Pharma Main Business
Table 96. Astellas Pharma Latest Developments
Table 97. Kaituo Pharmaceutical Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 98. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 99. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Kaituo Pharmaceutical Main Business
Table 101. Kaituo Pharmaceutical Latest Developments
Table 102. Hengrui Medicine Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 103. Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 104. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Hengrui Medicine Main Business
Table 106. Hengrui Medicine Latest Developments
Table 1. Androgen Receptor (AR) Antagonist Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Androgen Receptor (AR) Antagonist Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Steroidal AR Antagonists
Table 4. Major Players of Nonsteroidal AR Antagonists
Table 5. Global Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 6. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Table 7. Global Androgen Receptor (AR) Antagonist Revenue by Type (2019-2024) & ($ million)
Table 8. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2019-2024)
Table 9. Global Androgen Receptor (AR) Antagonist Sale Price by Type (2019-2024) & (US$/Ton)
Table 10. Global Androgen Receptor (AR) Antagonist Sale by Application (2019-2024) & (Kilotons)
Table 11. Global Androgen Receptor (AR) Antagonist Sale Market Share by Application (2019-2024)
Table 12. Global Androgen Receptor (AR) Antagonist Revenue by Application (2019-2024) & ($ million)
Table 13. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2019-2024)
Table 14. Global Androgen Receptor (AR) Antagonist Sale Price by Application (2019-2024) & (US$/Ton)
Table 15. Global Androgen Receptor (AR) Antagonist Sales by Company (2019-2024) & (Kilotons)
Table 16. Global Androgen Receptor (AR) Antagonist Sales Market Share by Company (2019-2024)
Table 17. Global Androgen Receptor (AR) Antagonist Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company (2019-2024)
Table 19. Global Androgen Receptor (AR) Antagonist Sale Price by Company (2019-2024) & (US$/Ton)
Table 20. Key Manufacturers Androgen Receptor (AR) Antagonist Producing Area Distribution and Sales Area
Table 21. Players Androgen Receptor (AR) Antagonist Products Offered
Table 22. Androgen Receptor (AR) Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Androgen Receptor (AR) Antagonist Sales by Geographic Region (2019-2024) & (Kilotons)
Table 26. Global Androgen Receptor (AR) Antagonist Sales Market Share Geographic Region (2019-2024)
Table 27. Global Androgen Receptor (AR) Antagonist Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Androgen Receptor (AR) Antagonist Sales by Country/Region (2019-2024) & (Kilotons)
Table 30. Global Androgen Receptor (AR) Antagonist Sales Market Share by Country/Region (2019-2024)
Table 31. Global Androgen Receptor (AR) Antagonist Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
Table 34. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2024)
Table 35. Americas Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 37. Americas Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 38. APAC Androgen Receptor (AR) Antagonist Sales by Region (2019-2024) & (Kilotons)
Table 39. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Region (2019-2024)
Table 40. APAC Androgen Receptor (AR) Antagonist Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 42. APAC Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 43. Europe Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
Table 44. Europe Androgen Receptor (AR) Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 46. Europe Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 47. Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Country (2019-2024) & (Kilotons)
Table 48. Middle East & Africa Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Type (2019-2024) & (Kilotons)
Table 50. Middle East & Africa Androgen Receptor (AR) Antagonist Sales by Application (2019-2024) & (Kilotons)
Table 51. Key Market Drivers & Growth Opportunities of Androgen Receptor (AR) Antagonist
Table 52. Key Market Challenges & Risks of Androgen Receptor (AR) Antagonist
Table 53. Key Industry Trends of Androgen Receptor (AR) Antagonist
Table 54. Androgen Receptor (AR) Antagonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Androgen Receptor (AR) Antagonist Distributors List
Table 57. Androgen Receptor (AR) Antagonist Customer List
Table 58. Global Androgen Receptor (AR) Antagonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 59. Global Androgen Receptor (AR) Antagonist Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Androgen Receptor (AR) Antagonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 61. Americas Androgen Receptor (AR) Antagonist Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Androgen Receptor (AR) Antagonist Sales Forecast by Region (2025-2030) & (Kilotons)
Table 63. APAC Androgen Receptor (AR) Antagonist Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Androgen Receptor (AR) Antagonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 65. Europe Androgen Receptor (AR) Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Forecast by Country (2025-2030) & (Kilotons)
Table 67. Middle East & Africa Androgen Receptor (AR) Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Androgen Receptor (AR) Antagonist Sales Forecast by Type (2025-2030) & (Kilotons)
Table 69. Global Androgen Receptor (AR) Antagonist Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Androgen Receptor (AR) Antagonist Sales Forecast by Application (2025-2030) & (Kilotons)
Table 71. Global Androgen Receptor (AR) Antagonist Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. R&D Systems Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 73. R&D Systems Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 74. R&D Systems Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. R&D Systems Main Business
Table 76. R&D Systems Latest Developments
Table 77. Bayer Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 79. Bayer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. Janssen Pharmaceuticals Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 83. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 84. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Janssen Pharmaceuticals Main Business
Table 86. Janssen Pharmaceuticals Latest Developments
Table 87. Pfizer Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 89. Pfizer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Astellas Pharma Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 93. Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 94. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Astellas Pharma Main Business
Table 96. Astellas Pharma Latest Developments
Table 97. Kaituo Pharmaceutical Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 98. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 99. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Kaituo Pharmaceutical Main Business
Table 101. Kaituo Pharmaceutical Latest Developments
Table 102. Hengrui Medicine Basic Information, Androgen Receptor (AR) Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 103. Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolios and Specifications
Table 104. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Hengrui Medicine Main Business
Table 106. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of Androgen Receptor (AR) Antagonist
Figure 2. Androgen Receptor (AR) Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Androgen Receptor (AR) Antagonist Sales Growth Rate 2019-2030 (Kilotons)
Figure 7. Global Androgen Receptor (AR) Antagonist Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Androgen Receptor (AR) Antagonist Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Androgen Receptor (AR) Antagonist Sales Market Share by Country/Region (2023)
Figure 10. Androgen Receptor (AR) Antagonist Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Steroidal AR Antagonists
Figure 12. Product Picture of Nonsteroidal AR Antagonists
Figure 13. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type in 2023
Figure 14. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2019-2024)
Figure 15. Androgen Receptor (AR) Antagonist Consumed in Prostate Cancer
Figure 16. Global Androgen Receptor (AR) Antagonist Market: Prostate Cancer (2019-2024) & (Kilotons)
Figure 17. Androgen Receptor (AR) Antagonist Consumed in Breast Cancer
Figure 18. Global Androgen Receptor (AR) Antagonist Market: Breast Cancer (2019-2024) & (Kilotons)
Figure 19. Androgen Receptor (AR) Antagonist Consumed in Others
Figure 20. Global Androgen Receptor (AR) Antagonist Market: Others (2019-2024) & (Kilotons)
Figure 21. Global Androgen Receptor (AR) Antagonist Sale Market Share by Application (2023)
Figure 22. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application in 2023
Figure 23. Androgen Receptor (AR) Antagonist Sales by Company in 2023 (Kilotons)
Figure 24. Global Androgen Receptor (AR) Antagonist Sales Market Share by Company in 2023
Figure 25. Androgen Receptor (AR) Antagonist Revenue by Company in 2023 ($ millions)
Figure 26. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company in 2023
Figure 27. Global Androgen Receptor (AR) Antagonist Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 30. Americas Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 31. APAC Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 32. APAC Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 33. Europe Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 34. Europe Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 36. Middle East & Africa Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 37. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Country in 2023
Figure 38. Americas Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
Figure 39. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 40. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 41. United States Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Region in 2023
Figure 46. APAC Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2019-2024)
Figure 47. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 48. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 49. China Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 53. India Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Country in 2023
Figure 57. Europe Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
Figure 58. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 59. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 60. Germany Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 61. France Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 68. Egypt Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Androgen Receptor (AR) Antagonist in 2023
Figure 74. Manufacturing Process Analysis of Androgen Receptor (AR) Antagonist
Figure 75. Industry Chain Structure of Androgen Receptor (AR) Antagonist
Figure 76. Channels of Distribution
Figure 77. Global Androgen Receptor (AR) Antagonist Sales Market Forecast by Region (2025-2030)
Figure 78. Global Androgen Receptor (AR) Antagonist Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Androgen Receptor (AR) Antagonist Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Androgen Receptor (AR) Antagonist Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Androgen Receptor (AR) Antagonist
Figure 2. Androgen Receptor (AR) Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Androgen Receptor (AR) Antagonist Sales Growth Rate 2019-2030 (Kilotons)
Figure 7. Global Androgen Receptor (AR) Antagonist Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Androgen Receptor (AR) Antagonist Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Androgen Receptor (AR) Antagonist Sales Market Share by Country/Region (2023)
Figure 10. Androgen Receptor (AR) Antagonist Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Steroidal AR Antagonists
Figure 12. Product Picture of Nonsteroidal AR Antagonists
Figure 13. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type in 2023
Figure 14. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2019-2024)
Figure 15. Androgen Receptor (AR) Antagonist Consumed in Prostate Cancer
Figure 16. Global Androgen Receptor (AR) Antagonist Market: Prostate Cancer (2019-2024) & (Kilotons)
Figure 17. Androgen Receptor (AR) Antagonist Consumed in Breast Cancer
Figure 18. Global Androgen Receptor (AR) Antagonist Market: Breast Cancer (2019-2024) & (Kilotons)
Figure 19. Androgen Receptor (AR) Antagonist Consumed in Others
Figure 20. Global Androgen Receptor (AR) Antagonist Market: Others (2019-2024) & (Kilotons)
Figure 21. Global Androgen Receptor (AR) Antagonist Sale Market Share by Application (2023)
Figure 22. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application in 2023
Figure 23. Androgen Receptor (AR) Antagonist Sales by Company in 2023 (Kilotons)
Figure 24. Global Androgen Receptor (AR) Antagonist Sales Market Share by Company in 2023
Figure 25. Androgen Receptor (AR) Antagonist Revenue by Company in 2023 ($ millions)
Figure 26. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Company in 2023
Figure 27. Global Androgen Receptor (AR) Antagonist Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 30. Americas Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 31. APAC Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 32. APAC Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 33. Europe Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 34. Europe Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Androgen Receptor (AR) Antagonist Sales 2019-2024 (Kilotons)
Figure 36. Middle East & Africa Androgen Receptor (AR) Antagonist Revenue 2019-2024 ($ millions)
Figure 37. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Country in 2023
Figure 38. Americas Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
Figure 39. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 40. Americas Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 41. United States Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Region in 2023
Figure 46. APAC Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2019-2024)
Figure 47. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 48. APAC Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 49. China Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 53. India Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Country in 2023
Figure 57. Europe Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2019-2024)
Figure 58. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 59. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 60. Germany Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 61. France Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Androgen Receptor (AR) Antagonist Sales Market Share by Application (2019-2024)
Figure 68. Egypt Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Androgen Receptor (AR) Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Androgen Receptor (AR) Antagonist in 2023
Figure 74. Manufacturing Process Analysis of Androgen Receptor (AR) Antagonist
Figure 75. Industry Chain Structure of Androgen Receptor (AR) Antagonist
Figure 76. Channels of Distribution
Figure 77. Global Androgen Receptor (AR) Antagonist Sales Market Forecast by Region (2025-2030)
Figure 78. Global Androgen Receptor (AR) Antagonist Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Androgen Receptor (AR) Antagonist Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Androgen Receptor (AR) Antagonist Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Androgen Receptor (AR) Antagonist Revenue Market Share Forecast by Application (2025-2030)
